Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Bruce

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Current Alzheimer Research|August 14, 2014
Severe psychiatric disorders in mid-life and risk of dementia in late- life (age 65-84 years): a population based case-control studyRenate R Zilkens, David G Bruce, Janine Duke, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2013
Australian population trends and disparities in cholinesterase inhibitor use, 2003 to 2010Renate R Zilkens, Janine Duke, Barbara Horner, et al.
The Medical Journal of Australia|March 4, 2008
Learning from error: identifying contributory causes of medication errors in an Australian hospitalPamela Nichols, Tandy-Sue Copeland, Ian A Craib, et al.
Diabetes Care|May 22, 2019
Response to Comment on Davis et al. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: the Fremantle Diabetes Study Phase I. Diabetes Care 2018;42:102-109Wendy A Davis, Emma J Hamilton, David G Bruce, et al.
Diabetes Care|November 21, 2018
Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase IWendy A Davis, Emma J Hamilton, David G Bruce, et al.
Journal of Diabetes and Its Complications|September 22, 2015
The interactive effects of type 2 diabetes mellitus and schizophrenia on all-cause mortality: The Fremantle Diabetes StudyWendy Angela Davis, Sergio E Starkstein, David G Bruce, et al.
Journal of Clinical Medicine|December 23, 2023
The Clinical Relevance of Diabetes Distress versus Major Depression in Type 2 Diabetes: A Latent Class Analysis from the Fremantle Diabetes Study Phase IIWendy A Davis, David G Bruce, Timothy M E Davis, et al.
Diabetologia|September 3, 2025
The relationship between shrunken pore syndrome/selective glomerular hypofiltration syndromes and all-cause mortality in the Fremantle Diabetes Study Phase II. Reply to Gu X, Wei Y [letter]David G Bruce, Wendy A Davis, S A Paul Chubb, et al.
The Medical Journal of Australia|April 6, 2006
Glycaemic levels triggering intensification of therapy in type 2 diabetes in the community: the Fremantle Diabetes StudyTimothy M E Davis, Wendy A Davis Cyllene Uwa Edu Au, David G Bruce
Diabetologia|April 21, 2025
The relationship between shrunken pore syndrome and all-cause mortality in people with type 2 diabetes and normal renal function: the Fremantle Diabetes Study Phase IIDavid G Bruce, Wendy A Davis, S A Paul Chubb, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Current Alzheimer Research|August 14, 2014
Severe psychiatric disorders in mid-life and risk of dementia in late- life (age 65-84 years): a population based case-control studyRenate R Zilkens, David G Bruce, Janine Duke, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2013
Australian population trends and disparities in cholinesterase inhibitor use, 2003 to 2010Renate R Zilkens, Janine Duke, Barbara Horner, et al.
The Medical Journal of Australia|March 4, 2008
Learning from error: identifying contributory causes of medication errors in an Australian hospitalPamela Nichols, Tandy-Sue Copeland, Ian A Craib, et al.
Diabetes Care|May 22, 2019
Response to Comment on Davis et al. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: the Fremantle Diabetes Study Phase I. Diabetes Care 2018;42:102-109Wendy A Davis, Emma J Hamilton, David G Bruce, et al.
Diabetes Care|November 21, 2018
Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase IWendy A Davis, Emma J Hamilton, David G Bruce, et al.
Journal of Diabetes and Its Complications|September 22, 2015
The interactive effects of type 2 diabetes mellitus and schizophrenia on all-cause mortality: The Fremantle Diabetes StudyWendy Angela Davis, Sergio E Starkstein, David G Bruce, et al.
Journal of Clinical Medicine|December 23, 2023
The Clinical Relevance of Diabetes Distress versus Major Depression in Type 2 Diabetes: A Latent Class Analysis from the Fremantle Diabetes Study Phase IIWendy A Davis, David G Bruce, Timothy M E Davis, et al.
Diabetologia|September 3, 2025
The relationship between shrunken pore syndrome/selective glomerular hypofiltration syndromes and all-cause mortality in the Fremantle Diabetes Study Phase II. Reply to Gu X, Wei Y [letter]David G Bruce, Wendy A Davis, S A Paul Chubb, et al.
The Medical Journal of Australia|April 6, 2006
Glycaemic levels triggering intensification of therapy in type 2 diabetes in the community: the Fremantle Diabetes StudyTimothy M E Davis, Wendy A Davis Cyllene Uwa Edu Au, David G Bruce
Diabetologia|April 21, 2025
The relationship between shrunken pore syndrome and all-cause mortality in people with type 2 diabetes and normal renal function: the Fremantle Diabetes Study Phase IIDavid G Bruce, Wendy A Davis, S A Paul Chubb, et al.
Pageof 9